Health at a Glance 2025: Latvia
Table of contents
Health at a Glance provides a comprehensive set of indicators on population health and health system performance across OECD Members, Key Partners and accession candidate countries. These indicators cover health status, non-medical determinants and risk factors, access to and quality of healthcare, health spending and health system resources. Analysis draws from the latest comparable official national statistics and other sources.
This country note shows how Latvia compares to other OECD countries across a selection of key indicators from the report.
Latvia performs better than the OECD average on 1 out of 10 key indicators measuring health status and risk factors for health (missing data on 1 of these indicators).
Source: OECD Health Statistics 2025.
Health status
In Latvia, life expectancy was 75.6 years, 5.5 years below the OECD average.
Preventable mortality was 258 per 100 000 in Latvia (higher than the OECD average of 145); with treatable mortality at 154 per 100 000 (higher than the OECD average of 77).
Suicide rates were 13 per 100 000 population in Latvia, compared to the OECD average of 11 deaths per 100 000 population.
15.1% of people in Latvia rated their health as bad or very bad (OECD average 8.0%).
Risk factors for health
Daily smoking prevalence in Latvia, at 22.6%, was higher than the OECD average of 14.8%.
Alcohol consumption was higher than the OECD average; at 11.7 litres per capita in Latvia versus 8.5.
18% of adults in Latvia did not perform sufficient physical activity, lower than the OECD average of 30%.
No comparable data are available on self-reported obesity prevalence.
People in Latvia were exposed to 11.8 micrograms of ambient particulate matter (PM2.5) per cubic metre (OECD average 11.2 micrograms).
See Health at a Glance 2025, Chapter 3 and Chapter 4 for further details on these and related indicators.
Latvia performs better than the OECD average on 3 out of 10 key indicators measuring access to and quality of care (missing data on 1 of these indicators).
Note: AMI: Acute Myocardial Infarction. DDD: Defined Daily Dose.
Source: OECD Health Statistics 2025.
Access to care
In Latvia, all of the population is covered for a core set of services, while 98% of population is covered on average of OECD countries.
54% of people in Latvia were satisfied with the availability of quality healthcare (OECD average 64%).
In terms of financial coverage, 60% of spending in Latvia was covered by mandatory prepayment, lower than the OECD average of 75%.
8.4% of people in Latvia expressed unmet needs for healthcare, compared to the OECD average of 3.4%.
Quality of care
97% of eligible children were vaccinated against DTP in Latvia, higher than the OECD average.
36% of women in Latvia were screened for breast cancer, less than the OECD average of 55%.
Latvia prescribed 13 defined daily doses of antibiotics per 1 000 population, less than the OECD average of 16.
No comparable data are available on avoidable admissions.
In Latvia, 30‑day mortality after AMI was 13.5% (OECD average 6.5%), and 17.3% after stroke (OECD average 7.7%), based on unlinked data.
See Health at a Glance 2025, Chapter 5 and Chapter 6 for further details on these and related indicators.
Latvia has more resources than the OECD average on 3 out of 10 key indicators measuring health system resources (missing data on 1 of these indicators).
Note: CT: Computer Tomography; MRI: Magnetic Resonance Imaging; PET: Positron Emission Tomography.
Source: OECD Health Statistics 2025.
Health spending
Latvia spends $3 411 per capita on health, less than the OECD average of $5 967 (USD PPP).
This is equal to 7.6% of GDP, compared to 9.3% on average in the OECD.
Latvia spends 2.6% of total health spending on prevention in current health expenditure, similar to the OECD average of 3.4%.
Health workforce
There are 3.4 practising doctors per 1 000 population in Latvia (OECD average 3.9); and 4.2 practising nurses (OECD average 9.2).
No comparable data are available on long-term care workers.
There are 86 pharmacists per 100 000 population in Latvia, compared to the OECD average of 86.
Hospitals and equipment
Latvia has 5.0 hospital beds per 1 000 population, similar to the OECD average of 4.2.
There are 65 CT scanners, MRI units and PET scanners per million population in Latvia (OECD average 51).
The share of generics in the pharmaceutical market (by volume) is 77% in Latvia, compared to the OECD average of 56%.
See Health at a Glance 2025, Chapter 5, Chapter 7, Chapter 8, Chapter 9 and Chapter 10 for further details on these and related indicators.
Health at a Glance provides a comprehensive set of indicators on population health and health system performance across OECD Members, Key Partners and accession candidate countries. These indicators cover health status, non-medical determinants and risk factors, access to and quality of healthcare, health spending and health system resources. Analysis draws from the latest comparable official national statistics and other sources.
Alongside indicator-by-indicator analysis, an overview chapter summarises the comparative performance of countries and major trends. This edition also includes a thematic chapter on gender and health.
This work is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and arguments employed herein do not necessarily reflect the official views of the Member countries of the OECD.
This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area.
The statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law.
The full book is available in English: OECD (2025), Health at a Glance 2025, OECD Publishing, Paris, https://doi.org/10.1787/8f9e3f98-en.
© OECD 2025
Attribution 4.0 International (CC BY 4.0)
This work is made available under the Creative Commons Attribution 4.0 International licence. By using this work, you accept to be bound by the terms of this licence (https://creativecommons.org/licenses/by/4.0/).
Attribution – you must cite the work.
Translations – you must cite the original work, identify changes to the original and add the following text: In the event of any discrepancy between the original work and the translation, only the text of the original work should be considered valid.
Adaptations – you must cite the original work and add the following text: This is an adaptation of an original work by the OECD. The opinions expressed and arguments employed in this adaptation should not be reported as representing the official views of the OECD or of its Member countries.
Third-party material – the licence does not apply to third-party material in the work. If using such material, you are responsible for obtaining permission from the third party and for any claims of infringement.
You must not use the OECD logo, visual identity or cover image without express permission or suggest the OECD endorses your use of the work.
Any dispute arising under this licence shall be settled by arbitration in accordance with the Permanent Court of Arbitration (PCA) Arbitration Rules 2012. The seat of arbitration shall be Paris (France). The number of arbitrators shall be one.